LITTLE GREEN PHARMA LTD — Director's Dealing 2021

Sep 7, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity Little Green Pharma Ltd ACN 615 586 215

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Neale William Fong
Date of last notice	12 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	Riverpalm Pty Ltd ATF NW Fong Family Trust-Dr Fong is a directorDr Neale Fong ATF Damblock Trust-Dr Fong is a trustee
Date of change	6 September 2021
No. of securities held priorto change	Riverpalm Pty Ltd 296,154 Ordinary shares*Dr Neale Fong 716,413 Ordinary shares150,000 Retention Share Rights75,458 Director Share Rights
Class	Retention Share Rights
Number acquired	35,000

• The previous balance reported on 12 March 2021 did not include 46,154 shares purchased through the Company’s Share Purchase Plan on 11 March 2021 which was disclosed in the Share Purchase Plan Offer Booklet dated 15 February 2021.

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation	Nil consideration.
No. of securities held afterchange	Riverpalm Pty Ltd 296,154 Ordinary sharesDr Neale Fong 716,413 Ordinary shares185,000 Retention Share Rights75,458 Director Share Rights
Nature of changeExample:on-markettrade,off-markettrade, exercise of options, issue of securitiesunderdividendreinvestmentplan,participation inbuy-back	As approved by shareholders on 19 July 2021, issued as an incentivefor continued service, with securities vesting in February 2024.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Note: In the case of a company, interests which come within	paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this
Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
**Date of change **
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which theinterest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest after change

Part 3 – +Closed period

Interest after change Part 3 – +Closed period
Were the interests in the securities or contracts detailedabove traded during a +closed period where priorwritten clearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what datewas this provided?	N/A

• The previous balance reported on 12 March 2021 did not include 46,154 shares purchased through the Company’s Share Purchase Plan on 11 March 2021 which was disclosed in the Share Purchase Plan Offer Booklet dated 15 February 2021.

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 2

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/9/2001.

Name of entity Little Green Pharma Ltd ACN 615 586 215

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Michael David Lynch-Bell
Date of last notice	12 March 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest(including registered holder)Note: Provide details of the circumstancesgiving rise to the relevant interest.	N/A
Date of change	6 September 2021
No. of securities held priorto change	833,743 Ordinary shares300,000 Retention Share Rights
Class	Retention Share Rights
Number acquired	70,000
Number disposed	Nil
Value/ConsiderationNote: If consideration is non-cash, providedetails and estimated valuation	Nil consideration.

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after 833,743 Ordinary shares

change 370,000 Retention Share Rights Nature of change As approved by shareholders on 19 July 2021, issued as an incentive Example: on-market trade, off-market for continued service, with securities vesting in February 2024. trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder(if issued securities)
**Date of change **
No. and class of securities towhich interest related prior tochangeNote: Details are only required for a contract in relationto which theinterest has changed
Interest acquired
Interest disposed
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation
Interest after change

Part 3 – +Closed period

Interest after change Part 3 – +Closed period
Were the interests in the securities or contracts detailedabove traded during a +closed period where priorwritten clearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what datewas this provided?	N/A

• See chapter 19 for defined terms.

11/3/2002

Appendix 3Y Page 2